DSM Logo
NL0000009827
A0JLZ7
KDSKF

DSM

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, DSM has already paid €2.50 in dividends. The last payout was in May.

Financials

In the last year, DSM had revenue of €8.39B and net profit of €475M
(EUR) 2022
YoY
Revenue 8.39B 8.84%
Gross profit 2.69B 14.98%
Net profit 475M 36.41%
EBITDA 1.15B 32.65%

Fundamentals

Metric Value
Market capitalization
€763.73M
Number of shares
6.7M
52-week high/low
€157.30 - €105.80
Dividend yield
10.99%
Dividends TTM
€2.50
Beta
0.72
P/E ratio
41.62
PEG ratio
-0.98
P/B ratio
1.96
P/S ratio
0.09

Company profile

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Name
DSM
CEO
Dimitri de Vreeze
Headquarters Heerlen,
Netherlands
Website
Sector
Materials
Industry
Chemicals
IPO
01/01/1989
Employees 19,263

Ticker symbols

Exchange Symbol
Pnk
KDSKF
Euronext
DSM.AS
🍪

Parqet  uses cookies. Learn more